(Total Views: 919)
Posted On: 07/24/2020 6:12:36 PM
Post# of 154952
I would think that members of the Scientific Advisory Committee for Cytodyn would be extra familiar with the MOA of Leronlimab, wouldn't they?
Assuming that the DSMB likes what it sees with the Severe/Critical data, is it possible at some point that they talk with the SAC and get totally up to speed with the MOA and become advocates and spokespeople for Leronlimab also?
I think this possibility is important because breaking through the medical community's thick information skin seems very difficult.
Authority only seems to listen to authority and, even then, not so much.
Who will speak up for Leronlimab when they see stunning data and feel the urgency of the this moment of Pandemic?
Assuming that the DSMB likes what it sees with the Severe/Critical data, is it possible at some point that they talk with the SAC and get totally up to speed with the MOA and become advocates and spokespeople for Leronlimab also?
I think this possibility is important because breaking through the medical community's thick information skin seems very difficult.
Authority only seems to listen to authority and, even then, not so much.
Who will speak up for Leronlimab when they see stunning data and feel the urgency of the this moment of Pandemic?
(1)
(0)
